Cardiology

Top Story

VIDEO: ODYSSEY trials demonstrate PCSK9 inhibitor efficacy, raise awareness of HeFH

September 5, 2015

LONDON — In this video, Deepak L. Bhatt, MD, MPH, Chief Medical Editor of Cardiology Today’s Intervention, outlines results from four studies from the ODYSSEY program presented at the European Society of Cardiology Congress.

The four trials evaluated approximately 1,250 patients with familial hypercholesterolemia (FH) within the ODYSSEY program, assessing the use of the PCSK9 inhibitor alirocumab (Praluent, Sanofi/Regeneron) in addition to the maximally tolerated statin dose in this population.
Meeting News Coverage

CoreValve ADVANCE: TAVI safe for patients at intermediate, high surgical risk

September 4, 2015
LONDON — Complications up to 3 years after transcatheter aortic valve implantation were infrequent in both intermediate- and high-risk patients as indicated by…
Gilles Montalescot Meeting News CoveragePerspective

AEGEAN: Adherence program does not provide additional value to apixaban users

September 4, 2015
LONDON — An educational program on treatment adherence for users of apixaban did not provide any additional value at 6 months compared with the standard of care…
Jinwei Xie, MD In the Journals

Early anticoagulation balances antifibrinolysis after knee arthroplasty with tranexamic acid

September 4, 2015
Postoperative venous thromboembolism rates do not differ in patients who receive tranexamic acid when undergoing primary unilateral total knee arthroplasty, Chinese…
In the Journals

Lower fluoroscopy frame rate performs well in peripheral vascular interventions

September 4, 2015
Among patients who received peripheral vascular interventions, a fluoroscopy frame rate of 7.5 frames per second led to a reduced radiation dose and comparable success…
More News Headlines »
CME
Cardiology Case Consults

The Patient with Obesity

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with obesity.
More »
Meeting News Coverage Video
VIDEO: ARTS-HF results indicate benefits of finerenone for certain patients with HF

VIDEO: ARTS-HF results indicate benefits of finerenone for certain patients with HF

September 2, 2015
LONDON — In this video, Richard A. Chazal, MD, FACC, medical director of the Heart and Vascular Institute at Lee…
More »
CME
Managing Today's EP Challenges with NOAC Use

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
morganatic-roan